Garda Capital Partners’s DexCom DXCM Stock Holding History

Garda Capital Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-65,000	Closed	-$5.67M	–	161
2025 Q2	$5.67M	Sell	65,000 -44,300	-41%	-$3.47M	0.14%	174
2025 Q1	$7.46M	Buy	109,300 +97,300	+811%	+$7.94M	0.19%	168
2024 Q4	$933K	Hold	12,000	–	–	0.07%	161
2024 Q3	$804K	Sell	12,000 -35,800	-75%	-$2.94M	0.02%	426
2024 Q2	$5.42M	Buy	47,800 +12,000	+34%	+$1.52M	0.19%	148
2024 Q1	$4.97M	Buy	+35,800	New	+$4.5M	0.21%	141
2023 Q2	–	Sell	-26,000	Closed	-$3.02M	–	381
2023 Q1	$3.02M	Buy	+26,000	New	+$2.91M	0.15%	128

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Garda Capital Partners's DXCM Position: Q3 2025 in Review

Garda Capital Partners sold out of DexCom (DXCM) in Q3 2025, closing a stake of 6,652 shares — an estimated $581K sold.

Garda Capital Partners first reported a position in DXCM in Q2 2024 and held it in 5 quarters. The position peaked at $2.53M in Q1 2025. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

Garda Capital Partners reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
Garda Capital Partners sold 6,652 DexCom shares in Q3 2025, an estimated $581K.
Garda Capital Partners first reported a position in DexCom in Q2 2024 and held it in 5 quarters.
Garda Capital Partners's DexCom position peaked at $2.53M in Q1 2025.
911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Garda Capital Partners's 13F filing for Q3 2025, filed 10 Nov 2025.